CDKN1B and cancer: Taken together, these data support a model in PI3K-activated cancers, in which C-terminally phosphorylated p27 activates T-ISC expansion or maintenance though p27/STAT3/cJun-dependent PTPN12 loss and activation of Pyk2 and STAT3.